Mark Plavsic - Net Worth and Insider Trading

Mark Plavsic Net Worth

The estimated net worth of Mark Plavsic is at least $2 Million dollars as of 2024-11-13. Mark Plavsic is the Chief Technology Officer of Aura Biosciences Inc and owns about 121,132 shares of Aura Biosciences Inc (AURA) stock worth over $1 Million. Mark Plavsic is also the Chief Technical Officer of Fate Therapeutics Inc and owns about 123,705 shares of Fate Therapeutics Inc (FATE) stock worth over $294,418. Details can be seen in Mark Plavsic's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Plavsic has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Plavsic

To

Mark Plavsic Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Plavsic owns 1 companies in total, including Fate Therapeutics Inc (FATE) .

Click here to see the complete history of Mark Plavsic’s form 4 insider trades.

Insider Ownership Summary of Mark Plavsic

Ticker Comapny Transaction Date Type of Owner
FATE Fate Therapeutics Inc 2023-01-10 Chief Technical Officer

Mark Plavsic Latest Holdings Summary

Mark Plavsic currently owns a total of 2 stocks. Among these stocks, Mark Plavsic owns 121,132 shares of Aura Biosciences Inc (AURA) as of October 16, 2024, with a value of $1 Million and a weighting of 81.42%. Mark Plavsic also owns 123,705 shares of Fate Therapeutics Inc (FATE) as of January 10, 2023, with a value of $294,418 and a weighting of 18.58%.

Latest Holdings of Mark Plavsic

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AURA Aura Biosciences Inc 2024-10-16 121,132 10.65 1,290,056
FATE Fate Therapeutics Inc 2023-01-10 123,705 2.38 294,418

Holding Weightings of Mark Plavsic


Mark Plavsic Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Plavsic has made a total of 1 transactions in Aura Biosciences Inc (AURA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aura Biosciences Inc is the sale of 7,383 shares on October 16, 2024, which brought Mark Plavsic around $72,723.

According to the SEC Form 4 filings, Mark Plavsic has made a total of 2 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 3,418 shares on January 10, 2023, which brought Mark Plavsic around $17,910.

Insider Trading History of Mark Plavsic

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Plavsic Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Plavsic Ownership Network

Ownership Network List of Mark Plavsic

No Data

Ownership Network Relation of Mark Plavsic

Insider Network Chart

Mark Plavsic Owned Company Details

What does Fate Therapeutics Inc do?

Who are the key executives at Fate Therapeutics Inc?

Mark Plavsic is the Chief Technical Officer of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .

Fate Therapeutics Inc (FATE) Insider Trades Summary

Over the past 18 months, Mark Plavsic made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 18,777 shares made by Dulac Edward J Iii , a net sale of 4,725 shares made by Yuan Xu , and a net sale of 35,237 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,255 shares of Fate Therapeutics Inc (FATE) were sold and 44,630 shares were bought by its insiders, resulting in a net sale of 43,625 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fate Therapeutics Inc Insider Transactions

No Available Data

Mark Plavsic Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Plavsic. You might contact Mark Plavsic via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court Ste 200, San Diego Ca 92121.